Rapid Microbiology Testing Market
Report Code
MD 6602
Published in
Jun, 2026, By MarketsandMarkets™
Rapid Microbiology Testing Market by Product (Instruments (Mass Spectrometers), Consumables), Method (Nucleic Acid-based), Application (Industrial Testing (Food & Beverage), Clinical Diagnosis), End User (Hospitals), & Region - Global Forecast to 2031
$5.69B
MARKET SIZE, 2026
$9.00B
MARKET SIZE, 2031
9.6%
CAGR (2026-2031)
2026-2031
FORECAST PERIOD
RAPID MICROBIOLOGY TESTING MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global rapid microbiology testing market is projected to grow from USD 5.69 billion in 2026 to USD 9.00 billion by 2031, at a CAGR of 9.6% during the forecast period. The market was valued at USD 5.22 billion in 2025. The rapid microbiology testing market is driven by the rising prevalence of infectious diseases, increasing demand for faster microbial detection, growing pharmaceutical and biopharmaceutical production, and stringent contamination control regulations. Advancements in molecular diagnostics, automation technologies, and rapid sterility testing systems are further supporting market growth globally.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Market Size (2025): USD 5.22 Billion
Market Size (2026): USD 5.69 Billion
Projected Market Size (2031): USD 9.00 Billion
CAGR (2026–2031): 9.6% -
SEGMENT LEADERSHIP:
Fastest-Growing Region: Asia Pacific is expected to witness the fastest growth in the rapid microbiology testing market.
Product Leader: Reagents & kits accounted for the largest share of 52.4% in 2025.
Method Leader: Growth-based rapid microbiology testing accounted for the largest market share of 40.2% in 2025.
Application Leader: The industrial testing segment accounted for the largest market share of 56.8% in 2025.
Fastest-Growing End User: Pharmaceutical & biotechnology companies are projected to witness the highest CAGR during the forecast period. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
bioMérieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific, Inc. (US) were identified as star players, supported by their strong market presence and extensive product portfolios.
Don Whitley Scientific Limited (UK), Gradientech (Sweden), Rqmicro AG (Switzerland), and Colifast AS (Norway) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.
The rapid microbiology testing market is experiencing growth due to the rising prevalence of infectious diseases, increasing incidence of healthcare-associated infections, and growing demand for faster microbial detection methods across healthcare and industrial settings. The expansion of pharmaceutical and biopharmaceutical manufacturing activities is increasing the need for rapid sterility testing and contamination control solutions. Additionally, advancements in molecular diagnostics, laboratory automation, PCR technologies, and automated microbial identification systems are improving testing efficiency and turnaround times.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The influence of end users on the rapid microbiology testing market is driven by the increasing demand for faster microbial detection, stringent contamination control requirements, and the growing adoption of automated diagnostic technologies. Key end users of rapid microbiology testing solutions include hospitals, clinical laboratories, pharmaceutical & biotechnology companies, food & beverage manufacturers, environmental testing laboratories, and research institutions. High-growth applications in this market include infectious disease diagnosis, sterility testing, antimicrobial susceptibility testing, pharmaceutical quality control, food safety testing, environmental monitoring, and biopharmaceutical manufacturing.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Increasing prevalence of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases
-
Technological advancements in automated microbiology and MALDI-TOF platforms
RESTRAINTS
Impact
Level
Level
-
High capital investments and low cost-benefit ratio
-
Regulatory complexity and limited reimbursement coverage
OPPORTUNITIES
Impact
Level
Level
-
Growing demand for rapid microbiology testing in emerging economies
-
Expansion of rapid microbial testing applications
CHALLENGES
Impact
Level
Level
-
Workflow inefficiencies and skilled workforce shortages
-
High investment in automated microbial identification systems
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing prevalence of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases
The rising prevalence of healthcare-associated infections, antimicrobial-resistant pathogens, and infectious diseases is significantly increasing the demand for rapid microbiology testing solutions. Healthcare providers and pharmaceutical manufacturers are increasingly adopting rapid microbial detection technologies to enable faster diagnosis, improve infection control, and support timely treatment decisions.
Restraint: High capital investments and low cost-benefit ratio
The adoption of advanced rapid microbiology testing systems is often limited due to high capital investment requirements associated with automated instruments, molecular diagnostic platforms, and laboratory automation infrastructure. In addition, maintenance costs, software integration expenses, and the need for skilled laboratory personnel can increase operational costs, particularly for small and mid-sized laboratories.
Opportunity: Growing demand for rapid microbiology testing in emerging economies
Emerging economies present significant growth opportunities for the rapid microbiology testing market due to expanding healthcare infrastructure, increasing pharmaceutical manufacturing activities, and rising awareness regarding infection control and product safety. Governments and private healthcare organizations in countries such as China, India, Brazil, and Southeast Asian nations are investing heavily in laboratory modernization and molecular diagnostics. Increasing food safety concerns, growing biopharmaceutical production, and rising healthcare expenditure are further expected to drive market expansion in these regions.
Challenge: Workflow inefficiencies and skilled workforce shortages
Operational challenges such as complex laboratory workflows, lack of trained microbiology professionals, and difficulties in integrating advanced rapid testing systems with existing laboratory infrastructure may hinder market growth. In addition, variability in regulatory requirements, validation procedures, and quality assurance standards across regions can create implementation challenges for manufacturers and end users.
RAPID MICROBIOLOGY TESTING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides automated microbial identification, antimicrobial susceptibility testing, rapid sterility testing, and molecular microbiology solutions for clinical diagnostics and pharmaceutical quality control applications | Enables faster pathogen identification | Improved infection control | Reduced turnaround times | Enhanced regulatory compliance for healthcare and industrial laboratories |
 |
Uses MALDI-TOF mass spectrometry platforms for rapid microbial identification in clinical microbiology and pharmaceutical testing laboratories | Delivers high-throughput microbial identification with improved accuracy | Lower per-test costs | Faster laboratory workflows compared to conventional culture-based methods |
 |
Offers molecular diagnostic systems, automated microbiology instruments, and rapid pathogen detection solutions through its life sciences and diagnostics businesses | Supports rapid detection of infectious pathogens | Enhances laboratory automation | Improves operational efficiency in hospitals and research laboratories |
 |
Develops rapid molecular diagnostic and PCR-based microbiology testing systems for infectious disease detection and antimicrobial resistance monitoring | Improves diagnostic accuracy | Accelerates clinical decision-making | Supports timely treatment interventions in healthcare settings |
 |
Provides PCR systems, culture media, microbial identification platforms, sterility testing solutions, and environmental monitoring products for healthcare and industrial applications | Enhances contamination detection | Supports rapid product release in pharmaceutical manufacturing | Improves microbiology laboratory productivity and quality assurance processes |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The rapid microbiology testing ecosystem comprises manufacturers, distributors, and end users, each playing a critical role in delivering rapid microbial detection and identification solutions. Manufacturers develop and commercialize rapid microbiology instruments, molecular testing systems, and integrated diagnostic platforms. Distributors support product availability and market reach through their global distribution networks. End users, including hospitals, clinical laboratories, pharmaceutical and biotechnology companies, food & beverage manufacturers, and environmental testing laboratories utilize these solutions to accelerate pathogen detection, ensure product quality, support regulatory compliance, and improve operational efficiency.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Rapid Microbiology Testing Market, by Product
In 2025, reagents & kits held the largest share of the rapid microbiology testing market and are expected to maintain their dominance through 2026. This is primarily driven by the recurring demand for culture media, assay kits, primers, probes, stains, and antimicrobial susceptibility testing reagents used in routine microbiology workflows. Increasing testing volumes across hospitals, pharmaceutical companies, and food testing laboratories, along with the growing adoption of molecular microbiology and automated testing platforms, continue to support long-term segmental growth globally.
Rapid Microbiology Testing Market, by Method
In 2025, the growth-based rapid microbiology testing method accounted for the largest maraket share due to the extensive use of this method in sterility testing, environmental monitoring, and microbial contamination detection. These methods are widely adopted because of their strong regulatory acceptance, reliability in detecting viable microorganisms, and compatibility with pharmaceutical quality assurance workflows.
Rapid Microbiology Testing Market, by Application
In 2025, industrial testing applications captured the largest share of the rapid microbiology testing market, driven by increasing demand for sterility assurance, contamination monitoring, and quality control across pharmaceuticals, biopharmaceuticals, food & beverages, and environmental testing industries. Growing regulatory requirements related to product safety and microbial contamination prevention are accelerating the adoption of rapid microbiology technologies. In addition, rising pharmaceutical manufacturing activities and increasing focus on operational efficiency are supporting sustained growth in industrial testing applications globally.
Rapid Microbiology Testing Market, by End User
In 2025, the hospitals, clinical laboratories, & ASCs segment held the largest share of the rapid microbiology testing market due to the rising demand for infectious disease testing and increasing prevalence of healthcare-associated infections. The growing adoption of rapid microbial identification systems, molecular diagnostics, and antimicrobial susceptibility testing solutions in healthcare settings is driving segmental growth. Additionally, increasing emphasis on early diagnosis, faster clinical decision-making, and improved patient outcomes continues to support demand for rapid microbiology testing technologies across hospitals and diagnostic laboratories globally.
REGION
Asia Pacific to be fastest-growing region in global rapid microbiology testing market during forecast period
The Asia Pacific region is expected to experience the highest CAGR in the rapid microbiology testing market from 2026 to 2031, driven by expanding healthcare infrastructure, increasing pharmaceutical and biopharmaceutical manufacturing activities, and rising adoption of rapid molecular diagnostic technologies. Countries such as China, India, Japan, and South Korea are witnessing significant investments in laboratory modernization, infection control programs, and healthcare automation, creasting growth opportunities for the rapid microbiology testing market.
RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX
In the rapid microbiology testing market, bioMérieux (France) stands out as a dominant player (Star) due to its strong portfolio of automated microbial identification systems, antimicrobial susceptibility testing platforms, molecular diagnostics solutions, and rapid sterility testing technologies. The company benefits from its extensive global presence; strong regulatory expertise; and broad customer base across hospitals, clinical laboratories, and pharmaceutical companies. In contrast, Merck KGaA (Germany) is recognized as an emerging leader owing to its expanding portfolio of rapid microbiological testing solutions for pharmaceutical quality control, including rapid sterility testing, microbial contamination detection, and environmental monitoring products. The company continues to strengthen its position through investments in bioprocessing and life science technologies, strategic collaborations, and innovative solutions that support faster and more efficient microbiological quality assurance.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- bioMérieux (France)
- Waters Corporation (US)
- Danaher Corporation (US)
- Abbott Laboratories (US)
- Thermo Fisher Scientific, Inc. (US)
- Bruker Corporation (US)
- QuidelOrtho Corporation (US)
- Sartorius AG (Germany)
- Merck KGaA (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Charles River Laboratories International, Inc. (US)
- Neogen Corporation (US)
- Bio-Rad Laboratories, Inc. (US)
- Shimadzu Corporation (Japan)
- Rapid Micro Biosystems, Inc. (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 5.22 Billion |
| Market Forecast in 2031 (Value) | USD 9.00 Billion |
| Growth Rate | CAGR of 9.6 % from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion), Volume ( Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
WHAT IS IN IT FOR YOU: RAPID MICROBIOLOGY TESTING MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Country-wise analysis of rapid microbiology testing market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa | Detailed analysis and profiling of up to five additional market players |
|
| Market share analysis and competitive benchmarking of key rapid microbiology testing companies | Further breakdown of the rapid microbiology testing market into specific countries for Rest of Europe, Rest of Asia Pacific, Rest of Latin America, and Rest of Middle East & Africa | Enhanced regional granularity through additional country-level segmentation, including Germany, the UK, France, Italy, Spain, and Rest of Europe; China, Japan, India, South Korea, Australia and Rest of Asia Pacific; Brazil, Mexico, and Rest of Latin America, along with dedicated analysis for the Middle East & Africa; United Arab Emirates, Saudi Arabia, and Rest of Middle East & Africa |
| Pricing analysis of rapid microbiology testing consumables and instruments | Country-wise regulatory and reimbursement landscape analysis for rapid microbiology testing | Broadened market segmentation framework with the inclusion of end user segmentation covering hospitals, cinical laboratories, & ASCs, pharmaceutical & biotechnology companies, food & beverage companies, environmental & water testing laboratories, and other end users |
RECENT DEVELOPMENTS
- April 2026 : bioMérieux SA (France) launched BIOFIRE SPOTFIRE for pharmaceutical industries, a rapid molecular mycoplasma testing platform for pharmaceutical QC applications, delivering results in less than one hour.
- March 2026 : bioMérieux (France) received IVDR CE marking for near-patient respiratory and sore throat molecular diagnostic panels for rapid infectious disease detection, in about 15 minutes, across Europe.
- December 2025 : Waters Corporation (US) expanded respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe through IVDR-certified VIASURE assays developed by Certest Biotec for use on the BD MAX System, enhancing automated molecular pathogen detection capabilities.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
39
2
EXECUTIVE SUMMARY
44
3
PREMIUM INSIGHTS
49
4
MARKET OVERVIEW
Navigate the microbiology market's growth amid rising infections, tech advancements, and rapid testing demand.
53
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.2.1
DRIVERS
4.2.1.1
INCREASING BURDEN OF HEALTHCARE-ASSOCIATED INFECTIONS (HAIS), ANTIMICROBIAL RESISTANCE (AMR), AND INFECTIOUS DISEASES
4.2.1.2
TECHNOLOGICAL ADVANCEMENTS IN AUTOMATED MICROBIOLOGY AND MALDI-TOF PLATFORMS
4.2.1.3
GROWING FOOD SAFETY CONCERNS AND RISING INCIDENCE OF FOODBORNE ILLNESSES
4.2.1.4
INCREASING R&D IN MICROBIOLOGY AND INFECTIOUS DISEASES
4.2.2
RESTRAINTS
4.2.2.1
HIGH CAPITAL INVESTMENTS AND LOW COST-BENEFIT RATIO
4.2.2.2
UNFAVORABLE REGULATORY AND REIMBURSEMENT SCENARIO
4.2.2.3
SHORTAGE OF SKILLED PERSONNEL
4.2.3
OPPORTUNITIES
4.2.3.1
GROWING DEMAND FOR RAPID MICROBIOLOGY TESTING IN EMERGING ECONOMIES
4.2.3.2
EXPANSION OF RAPID MICROBIAL TESTING APPLICATIONS
4.2.4
CHALLENGES
4.2.4.1
OPERATIONAL BARRIERS
4.2.4.2
HIGH INVESTMENT FOR AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN RAPID MICROBIOLOGY TESTING MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1
KEY MOVES AND STRATEGIC FOCUS
5
INDUSTRY TRENDS
Navigate competitive pressures with strategic insights from supply chain to pricing dynamics.
66
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
BARGAINING POWER OF SUPPLIERS
5.1.2
BARGAINING POWER OF BUYERS
5.1.3
THREAT OF NEW ENTRANTS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS AND FORECAST
5.3
SUPPLY CHAIN ANALYSIS
5.4
VALUE CHAIN ANALYSIS
5.5
ECOSYSTEM ANALYSIS
5.5.1
RAPID MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
5.6
PRICING ANALYSIS
5.6.1
AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2024–2026
5.6.2
AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024–2026
5.7
TRADE ANALYSIS
5.7.1
IMPORT SCENARIO (HS CODE 3822)
5.7.2
EXPORT SCENARIO (HS CODE 3822)
5.8
KEY CONFERENCES & EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT & FUNDING SCENARIO
5.11
CASE STUDY ANALYSIS
5.11.1
YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS
5.11.2
RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS
5.11.3
RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION
5.12
IMPACT OF US TARIFFS—RAPID MICROBIOLOGY TESTING MARKET
5.12.1
INTRODUCTION
5.12.2
KEY TARIFF RATES
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES/REGIONS
5.12.4.1
NORTH AMERICA
5.12.4.2
EUROPE
5.12.4.3
ASIA PACIFIC
5.12.5
IMPACT ON END-USE INDUSTRIES
5.12.5.1
HOSPITALS, CLINICAL LABORATORIES, AND ASCS
5.12.5.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.12.5.3
FOOD & BEVERAGE COMPANIES
5.12.5.4
ENVIRONMENTAL & WATER TESTING LABORATORIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations redefine rapid microbiology testing, unlocking new market potentials and patent opportunities.
86
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
AUTOMATED MULTIPLEX PCR SYSTEMS
6.1.2
BIOSENSORS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
OPTICAL IMMUNOSENSORS
6.2.2
ELECTROCHEMICAL IMMUNOSENSORS
6.3
ADJACENT TECHNOLOGIES
6.3.1
DIGITAL PCR (DPCR)
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5
PATENT ANALYSIS
6.5.1
LIST OF MAJOR PATENTS
6.6
FUTURE APPLICATIONS
6.7
IMPACT OF AI/GENERATIVE AI ON RAPID MICROBIOLOGY TESTING MARKET
6.7.1
INTRODUCTION
6.7.2
TOP USE CASES AND MARKET POTENTIAL
6.7.3
KEY COMPANIES IMPLEMENTING AI
6.7.4
FUTURE OF AI
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate complex regulations and eco-initiatives reshaping rapid microbiology testing globally.
93
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
INDUSTRY STANDARDS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN RAPID MICROBIOLOGY TESTING
7.2.1.1
ECO-FRIENDLY INITIATIVES
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock profit by addressing unmet needs and overcoming adoption barriers in key markets.
99
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
BUYING CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
8.5
MARKET PROFITABILITY
8.5.1
REVENUE POTENTIAL
8.5.2
COST DYNAMICS
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 76 Data Tables
106
9.1
INTRODUCTION
9.2
INSTRUMENTS
9.2.1
AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
9.2.1.1
EASE OF USE COMPARED TO CONVENTIONAL IDENTIFICATION PROCESSES TO SUPPORT MARKET GROWTH
9.2.2
MASS SPECTROMETERS
9.2.2.1
RAPID RESULTS ASSOCIATED WITH MASS SPECTROMETRY METHODS TO BOOST ADOPTION
9.2.3
BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
9.2.3.1
UNWANTED DETECTION OF NON-MICROBIAL ATP TO LIMIT MARKET ADOPTION
9.2.4
PCR SYSTEMS
9.2.4.1
GROWING USE OF STANDARD, REAL-TIME, AND QPCR FOR RAPID MICROBIAL TESTING TO SUPPORT GROWTH
9.2.5
CYTOMETERS
9.2.5.1
ABILITY TO DETECT VIABLE ORGANISMS TO FAVOR MARKET GROWTH
9.2.6
ACTIVE AIR SAMPLERS
9.2.6.1
CONVENIENCE AND EASE OF USE TO DRIVE DEMAND FOR ACTIVE AIR SAMPLERS
9.2.7
OTHER INSTRUMENTS
9.3
REAGENTS & KITS
9.3.1
STERILITY TESTING REAGENTS & KITS
9.3.1.1
INCREASING ADOPTION OF BET ASSAYS TO PROPEL MARKET GROWTH
9.3.2
OTHER REAGENTS & KITS
9.4
CONSUMABLES
9.4.1
DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
10
RAPID MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS
146
10.1
INTRODUCTION
10.2
GLOBAL: VOLUME OF MALDI-TOF MS MICROBIAL IDENTIFICATION SYSTEM INSTALLED BASE
11
RAPID MICROBIOLOGY TESTING MARKET, BY METHOD
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 32 Data Tables
147
11.1
INTRODUCTION
11.2
GROWTH-BASED RAPID MICROBIOLOGY TESTING
11.2.1
RISING DEMAND FOR GROWTH-BASED TESTING TO DRIVE MARKET
11.3
CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
11.3.1
HIGH SENSITIVITY, ACCURACY, AND SPECIFICITY OF CELLULAR COMPONENT-BASED METHODS TO BOOST MARKET
11.4
NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
11.4.1
HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH
11.5
VIABILITY-BASED RAPID MICROBIOLOGY TESTING
11.5.1
NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND
11.6
OTHER METHODS
12
RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 51 Data Tables
165
12.1
INTRODUCTION
12.2
INDUSTRIAL TESTING
12.2.1
FOOD & BEVERAGE TESTING
12.2.1.1
STRINGENT QUALITY CONTROL AND QUALITY ASSURANCE PROCESSES TO DRIVE MARKET GROWTH
12.2.2
PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
12.2.2.1
IMPROVED REGULATORY SCENARIO FOR DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH
12.2.3
ENVIRONMENTAL TESTING
12.2.3.1
GROWING FOCUS ON ENVIRONMENTAL MONITORING TO BOOST SEGMENTAL GROWTH
12.2.4
COSMETIC & PERSONAL CARE PRODUCTS TESTING
12.2.4.1
GROWING USE OF RAPID MICROBIOLOGY TESTING TO DETERMINE THE PRESENCE OF MICROBES FAVORS MARKET GROWTH
12.2.5
OTHER INDUSTRIAL TESTING APPLICATIONS
12.3
CLINICAL DISEASE DIAGNOSIS
12.3.1
HIGH BURDEN OF INFECTIOUS DISEASES AND HEALTHCARE-ASSOCIATED INFECTIONS TO PROPEL MARKET GROWTH
12.4
RESEARCH
12.4.1
INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH
13
RAPID MICROBIOLOGY TESTING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 31 Data Tables
195
13.1
INTRODUCTION
13.2
HOSPITALS, CLINICAL LABORATORIES, AND ASCS
13.2.1
INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
13.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.3.1
STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND
13.4
FOOD & BEVERAGE COMPANIES
13.4.1
STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH
13.5
ENVIRONMENTAL & WATER TESTING LABORATORIES
13.5.1
GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND
13.6
OTHER END USERS
14
RAPID MICROBIOLOGY TESTING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 18 Countries | 193 Data Tables.
214
14.1
INTRODUCTION
14.2
NORTH AMERICA
14.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
14.2.2
US
14.2.2.1
INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
14.2.3
CANADA
14.2.3.1
SUPPORTIVE GOVERNMENT INITIATIVES AND INCREASED RESEARCH FUNDING TO BOOST MARKET
14.3
EUROPE
14.3.1
EUROPE: MACROECONOMIC OUTLOOK
14.3.2
GERMANY
14.3.2.1
FAVORABLE GOVERNMENT POLICIES TO PROPEL MARKET
14.3.3
FRANCE
14.3.3.1
FAVORABLE HEALTHCARE REFORMS AND INVESTMENTS IN DIAGNOSTIC INFRASTRUCTURE TO DRIVE MARKET
14.3.4
UK
14.3.4.1
EMPHASIS ON FOOD CONTAMINATION MONITORING AND HYGIENE CONTROLS TO DRIVE MARKET
14.3.5
ITALY
14.3.5.1
IMPROVED HEALTHCARE SERVICES AND BETTER DISEASE SURVEILLANCE TO SUPPORT MARKET GROWTH
14.3.6
SPAIN
14.3.6.1
WATER MONITORING MANDATE TO BOOST MARKET GROWTH
14.3.7
RUSSIA
14.3.7.1
STRENGTHENING WATER QUALITY SURVEILLANCE AND OUTBREAK RESPONSE DRIVES ADOPTION IN RUSSIA
14.3.8
REST OF EUROPE
14.4
ASIA PACIFIC
14.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
14.4.2
CHINA
14.4.2.1
INCREASING GOVERNMENT FOCUS ON DISEASE PREVENTION TO DRIVE MARKET
14.4.3
JAPAN
14.4.3.1
STRINGENT SAFETY LAWS AND FOODBORNE OUTBREAKS TO FUEL UPTAKE
14.4.4
INDIA
14.4.4.1
HIGH TARGET PATIENT POPULATION TO BOOST DEMAND
14.4.5
SOUTH KOREA
14.4.5.1
FAVORABLE GOVERNMENT INITIATIVES FOR MEDICAL TOURISM TO SUPPORT MARKET GROWTH
14.4.6
AUSTRALIA
14.4.6.1
FAVORABLE HEALTHCARE AUTOMATION TECHNIQUES TO SUPPORT MARKET GROWTH
14.4.7
REST OF ASIA PACIFIC
14.5
LATIN AMERICA
14.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
14.5.2
BRAZIL
14.5.2.1
IMPROVING HEALTHCARE INFRASTRUCTURE AND STRINGENT REGULATIONS TO FUEL MARKET
14.5.3
MEXICO
14.5.3.1
INCREASING PREVALENCE OF HIV TO DRIVE MARKET
14.5.4
REST OF LATIN AMERICA
14.6
MIDDLE EAST & AFRICA
14.6.1
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
14.6.2
SAUDI ARABIA
14.6.2.1
INCREASING FOCUS ON HEALTHCARE AUTOMATION TO DRIVE MARKET
14.6.3
UNITED ARAB EMIRATES (UAE)
14.6.3.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
14.6.4
REST OF MIDDLE EAST & AFRICA
15
COMPETITIVE LANDSCAPE
Discover strategic insights and market dynamics shaping leaders in rapid microbiology testing.
326
15.1
INTRODUCTION
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1
OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET
15.3
REVENUE ANALYSIS, 2023–2025
15.4
MARKET SHARE ANALYSIS, 2025
15.4.1
GLOBAL MARKET SHARE ANALYSIS, 2025
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1
STARS
15.5.2
EMERGING LEADERS
15.5.3
PERVASIVE PLAYERS
15.5.4
PARTICIPANTS
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1
COMPANY FOOTPRINT
15.5.5.2
REGION FOOTPRINT
15.5.5.3
PRODUCT FOOTPRINT
15.5.5.4
APPLICATION FOOTPRINT
15.5.5.5
END-USER FOOTPRINT
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1
PROGRESSIVE COMPANIES
15.6.2
RESPONSIVE COMPANIES
15.6.3
DYNAMIC COMPANIES
15.6.4
STARTING BLOCKS
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
15.7
COMPANY VALUATION & FINANCIAL METRICS
15.7.1
FINANCIAL METRICS
15.7.2
COMPANY VALUATION
15.8
BRAND/PRODUCT COMPARISON
15.9
COMPETITIVE SCENARIO
15.9.1
PRODUCT LAUNCHES & APPROVALS
15.9.2
DEALS
15.9.3
EXPANSIONS
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
344
16.1
KEY PLAYERS
16.1.1
BIOMÉRIEUX
16.1.1.1
BUSINESS OVERVIEW
16.1.1.2
PRODUCTS OFFERED
16.1.1.3
RECENT DEVELOPMENTS
16.1.1.3.1
PRODUCT LAUNCHES & APPROVALS
16.1.1.3.2
DEALS
16.1.1.3.3
OTHER DEVELOPMENTS
16.1.1.4
MNM VIEW
16.1.1.4.1
RIGHT TO WIN
16.1.1.4.2
STRATEGIC CHOICES
16.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
16.1.2
WATERS CORPORATION
16.1.3
DANAHER CORPORATION
16.1.4
ABBOTT LABORATORIES
16.1.5
THERMO FISHER SCIENTIFIC INC.
16.1.6
BRUKER CORPORATION
16.1.7
QUIDELORTHO CORPORATION
16.1.8
SARTORIUS AG
16.1.9
MERCK KGAA
16.1.10
F. HOFFMANN-LA ROCHE LTD
16.1.11
CHARLES RIVER LABORATORIES, INC.
16.1.12
NEOGEN CORPORATION
16.1.13
BIO-RAD LABORATORIES, INC.
16.1.14
SHIMADZU CORPORATION
16.1.15
RAPID MICRO BIOSYSTEMS, INC.
16.2
OTHER PLAYERS
16.2.1
DON WHITLEY SCIENTIFIC LIMITED
16.2.2
GRADIENTECH
16.2.3
RQMICRO AG
16.2.4
COLIFAST AS
16.2.5
HYGIENA LLC
16.2.6
COPAN DIAGNOSTICS INC.
16.2.7
PERKINELMER INC.
16.2.8
HARDY DIAGNOSTICS
16.2.9
CHARM SCIENCES
16.2.10
R-BIOPHARM
17
RESEARCH METHODOLOGY
414
17.1
RESEARCH DATA
17.2
RESEARCH APPROACH
17.2.1
SECONDARY RESEARCH
17.2.1.1
KEY DATA FROM SECONDARY SOURCES
17.2.2
PRIMARY DATA
17.2.2.1
PRIMARY SOURCES
17.2.2.2
KEY DATA FROM PRIMARY SOURCES
17.2.2.3
KEY INDUSTRY INSIGHTS
17.3
MARKET SIZE ESTIMATION
17.3.1
BOTTOM-UP APPROACH
17.3.1.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
17.3.1.2
APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
17.3.1.3
GROWTH FORECAST
17.3.2
TOP-DOWN APPROACH
17.4
MARKET BREAKDOWN AND DATA TRIANGULATION
17.5
MARKET SHARE ANALYSIS
17.6
RESEARCH ASSUMPTIONS
17.6.1
PARAMETRIC ASSUMPTIONS
17.6.2
GROWTH RATE ASSUMPTIONS
17.7
RESEARCH LIMITATIONS
17.8
RISK ASSESSMENT
18
APPENDIX
427
18.1
DISCUSSION GUIDE
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
CUSTOMIZATION OPTIONS
18.4
RELATED REPORTS
18.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE)
TABLE 2
TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024
TABLE 3
US: FOOD RECALLS AND REASONS, 2025
TABLE 4
US: FOOD RECALLS, BY SPECIES, 2025
TABLE 5
RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6
GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 7
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 8
EUROPE: MACROECONOMIC INDICATORS
TABLE 9
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 10
LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 11
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 12
AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 13
AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 14
IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 15
EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 16
RAPID MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 17
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 18
LIST OF MAJOR PATENTS PERTAINING TO RAPID MICROBIOLOGY TESTING MARKET, 2023–2025
TABLE 19
KEY COMPANIES IMPLEMENTING AI IN RAPID MICROBIOLOGY TESTING MARKET
TABLE 20
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
GLOBAL STANDARDS IN THE RAPID MICROBIOLOGY TESTING MARKET
TABLE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
TABLE 27
KEY BUYING CRITERIA, BY PRODUCT
TABLE 28
ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29
RAPID MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30
RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31
KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET
TABLE 32
RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 33
RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 34
NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 40
NORTH AMERICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
EUROPE: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
ASIA PACIFIC: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43
LATIN AMERICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44
MIDDLE EAST & AFRICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46
NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47
EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48
ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
MIDDLE EAST & AFRICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 52
NORTH AMERICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53
EUROPE: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
ASIA PACIFIC: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
LATIN AMERICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
MIDDLE EAST & AFRICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57
PCR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
NORTH AMERICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
EUROPE: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60
ASIA PACIFIC: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61
LATIN AMERICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62
MIDDLE EAST & AFRICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63
CYTOMETERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 64
NORTH AMERICA: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65
EUROPE: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66
ASIA PACIFIC: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67
LATIN AMERICA: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68
MIDDLE EAST & AFRICA: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69
ACTIVE AIR SAMPLERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 70
NORTH AMERICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71
EUROPE: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72
ASIA PACIFIC: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73
LATIN AMERICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74
MIDDLE EAST & AFRICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75
OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 76
NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77
EUROPE: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78
ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79
LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80
MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81
RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 82
RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 83
NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84
EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86
LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88
STERILITY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 89
NORTH AMERICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90
EUROPE: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91
ASIA PACIFIC: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92
LATIN AMERICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93
MIDDLE EAST & AFRICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94
OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 95
NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96
EUROPE: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97
ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98
LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99
MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100
RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 101
NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102
EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104
LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 106
GLOBAL: MALDI-TOF MS MICROBIAL IDENTIFICATION SYSTEM INSTALLED BASE VOLUME, 2024–2031 (UNITS)
TABLE 107
RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 108
TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
TABLE 109
GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 110
NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111
EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112
ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113
LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114
MIDDLE EAST & AFRICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115
CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 116
NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117
EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118
ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119
LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120
MIDDLE EAST & AFRICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121
NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 122
NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123
EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 124
ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 125
LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126
MIDDLE EAST & AFRICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127
VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 128
NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129
EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130
ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131
LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132
MIDDLE EAST & AFRICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 133
OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 134
NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135
EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136
ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 137
LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138
MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139
RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 140
RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141
RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 142
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147
RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 148
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 153
RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 154
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 158
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159
RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 160
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 163
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165
QUALITY REGULATIONS & STANDARDS FOR COSMETICS & PERSONAL CARE
TABLE 166
RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 167
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 170
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172
RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 173
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 175
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 178
RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 179
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 180
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184
RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY REGION, 2024–2031 (USD MILLION)
TABLE 185
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190
RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 191
RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, & ASCS, BY REGION, 2024–2031 (USD MILLION)
TABLE 192
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 196
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197
RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 198
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 201
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203
RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 204
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 206
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 208
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 209
RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 210
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 211
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 212
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 213
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 214
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 215
RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 216
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 217
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 218
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 219
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 220
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 221
RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 222
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 223
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 224
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 225
NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 228
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 229
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 230
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 231
US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 232
US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233
US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 234
US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 235
US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 236
US: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237
US: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 238
CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 239
CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240
CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241
CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 242
CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 243
CANADA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244
CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 245
EUROPE: MACROECONOMIC INDICATORS
TABLE 246
EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 247
EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 248
EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 249
EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250
EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 251
EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 252
EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 253
EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 254
GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 255
GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256
GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257
GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 258
GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 259
GERMANY: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 260
GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 261
FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 262
FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263
FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 264
FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 265
FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 266
FRANCE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267
FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 268
UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 269
UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270
UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271
UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 272
UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 273
UK: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274
UK: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 275
ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 276
ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277
ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278
ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 279
ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 280
ITALY: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281
ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 282
SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 283
SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 284
SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285
SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 286
SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 287
SPAIN: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288
SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 289
RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 290
RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291
RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292
RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 293
RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 294
RUSSIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295
RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 296
REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 297
REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298
REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 299
REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 300
REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 301
REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 302
REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 303
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 304
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 305
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 306
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 309
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 310
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 311
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 312
CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 313
CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314
CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315
CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 316
CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 317
CHINA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318
CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 319
JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 320
JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 321
JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 322
JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 323
JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 324
JAPAN: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 325
JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 326
INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 327
INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 328
INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 329
INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 330
INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 331
INDIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 332
INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 333
SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 334
SOUTH KOREA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 335
SOUTH KOREA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 336
SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 337
SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 338
SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 339
SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 340
AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 341
AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 342
AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 343
AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 344
AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 345
AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 346
AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 347
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 348
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 349
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 350
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 351
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 352
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 353
REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 354
LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 355
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 356
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 357
LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 358
LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 359
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 360
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 361
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 362
LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 363
BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 364
BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 365
BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 366
BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 367
BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 368
BRAZIL: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 369
BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 370
MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 371
MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 372
MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 373
MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 374
MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 375
MEXICO: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 376
MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 377
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 378
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 379
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 380
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 381
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 382
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 383
REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 384
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 385
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 386
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 387
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 388
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 389
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 390
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 391
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 392
MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 393
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 394
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 395
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 396
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 397
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 398
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 399
SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 400
UAE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 401
UAE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 402
UAE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 403
UAE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 404
UAE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 405
UAE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 406
UAE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 407
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 408
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 409
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 410
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 411
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 412
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 413
REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 414
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN RAPID MICROBIOLOGY TESTING MARKET, JANUARY 2023−JUNE 2026
TABLE 415
RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
TABLE 416
RAPID MICROBIOLOGY TESTING MARKET: REGION FOOTPRINT
TABLE 417
RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT
TABLE 418
RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT
TABLE 419
RAPID MICROBIOLOGY TESTING MARKET: END-USER FOOTPRINT
TABLE 420
RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 421
RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
TABLE 422
RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
TABLE 423
RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 424
RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2023–JUNE 2026
TABLE 425
RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026
TABLE 426
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 427
BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 428
BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 429
BIOMÉRIEUX: DEALS, JANUARY 2023–JUNE 2026
TABLE 430
BIOMÉRIEUX: OTHER DEVELOPMENTS, JANUARY 2023–JUNE 2026
TABLE 431
WATERS CORPORATION: COMPANY OVERVIEW
TABLE 432
WATERS CORPORATION: PRODUCTS OFFERED
TABLE 433
WATERS CORPORATION: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026
TABLE 434
WATERS CORPORATION: DEALS, JANUARY 2023–JUNE 2026
TABLE 435
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 436
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 437
DANAHER CORPORATION: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026
TABLE 438
DANAHER CORPORATION: DEALS, JANUARY 2023–JUNE 2026
TABLE 439
ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 440
ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 441
ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026
TABLE 442
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 443
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 444
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026
TABLE 445
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JUNE 2026
TABLE 446
BRUKER CORPORATION: COMPANY OVERVIEW
TABLE 447
BRUKER CORPORATION: PRODUCTS OFFERED
TABLE 448
BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 449
BRUKER CORPORATION: DEALS, JANUARY 2023–JUNE 2026
TABLE 450
QUIDELORTHO CORPORATION: COMPANY OVERVIEW
TABLE 451
QUIDELORTHO CORPORATION: PRODUCTS OFFERED
TABLE 452
QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 453
QUIDELORTHO CORPORATION: DEALS, JANUARY 2023–JUNE 2026
TABLE 454
QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2023–JUNE 2026
TABLE 455
SARTORIUS AG: COMPANY OVERVIEW
TABLE 456
SARTORIUS AG: PRODUCTS OFFERED
TABLE 457
MERCK KGAA: COMPANY OVERVIEW
TABLE 458
MERCK KGAA: PRODUCTS OFFERED
TABLE 459
MERCK KGAA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 460
F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
TABLE 461
F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 462
F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 463
F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2023–JUNE 2026
TABLE 464
CHARLES RIVER LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 465
CHARLES RIVER LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 466
CHARLES RIVER LABORATORIES, INC.: PRODUCT LAUNCHES
TABLE 467
CHARLES RIVER LABORATORIES, INC.: DEALS
TABLE 468
NEOGEN CORPORATION: COMPANY OVERVIEW
TABLE 469
NEOGEN CORPORATION: PRODUCTS OFFERED
TABLE 470
NEOGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 471
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 472
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 473
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 474
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–JUNE 2026
TABLE 475
SHIMADZU CORPORATION: COMPANY OVERVIEW
TABLE 476
SHIMADZU CORPORATION: PRODUCTS OFFERED
TABLE 477
SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2023–JUNE 2026
TABLE 478
RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 479
RAPID MICRO BIOSYSTEMS, INC: PRODUCTS OFFERED
TABLE 480
RAPID MICRO BIOSYSTEMS, INC.: DEALS, JANUARY 2023–JUNE 2026
TABLE 481
DON WHITLEY SCIENTIFIC LIMITED: COMPANY OVERVIEW
TABLE 482
GRADIENTECH: COMPANY OVERVIEW
TABLE 483
RQMICRO AG: COMPANY OVERVIEW
TABLE 484
COLIFAST AS: COMPANY OVERVIEW
TABLE 485
HYGIENA LLC: COMPANY OVERVIEW
TABLE 486
COPAN DIAGNOSTICS INC.: COMPANY OVERVIEW
TABLE 487
PERKINELMER INC.: COMPANY OVERVIEW
TABLE 488
HARDY DIAGNOSTICS: COMPANY OVERVIEW
TABLE 489
CHARM SCIENCES: COMPANY OVERVIEW
TABLE 490
R-BIOPHARM: COMPANY OVERVIEW
TABLE 491
RAPID MICROBIOLOGY TESTING MARKET: RISK ASSESSMENT
LIST OF FIGURES
FIGURE 1
RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION
FIGURE 2
KEY INSIGHTS AND MARKET HIGHLIGHTS
FIGURE 3
GLOBAL RAPID MICROBIOLOGY TESTING MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET, 2023–2025
FIGURE 5
DISRUPTIVE TRENDS IMPACTING GROWTH OF RAPID MICROBIOLOGY TESTING MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN RAPID MICROBIOLOGY TESTING MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8
INCREASING DEMAND FOR RAPID STERILITY TESTING, BIOBURDEN TESTING, AND ENVIRONMENTAL MONITORING TO DRIVE MARKET
FIGURE 9
REAGENTS & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10
GROWTH-BASED SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11
INDUSTRIAL TESTING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12
HOSPITALS, CLINICAL LABORATORIES, AND ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 13
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 14
RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16
RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17
RAPID MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS
FIGURE 18
RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
FIGURE 19
RAPID MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20
NUMBER OF DEALS & FUNDING ACTIVITIES IN RAPID MICROBIOLOGY TESTING MARKET
FIGURE 21
PATENT ANALYSIS FOR RAPID MICROBIOLOGY TESTING, JANUARY 2015–DECEMBER 2025
FIGURE 22
MARKET POTENTIAL OF AI IN RAPID MICROBIOLOGY TESTING MARKET
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
FIGURE 24
KEY BUYING CRITERIA, BY PRODUCT
FIGURE 25
NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
FIGURE 26
ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET, 2023–2025 (USD MILLION)
FIGURE 28
RAPID MICROBIOLOGY TESTING MARKET SHARE ANALYSIS, 2025 (GLOBAL)
FIGURE 29
RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30
RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT
FIGURE 31
RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32
EV/EBITDA OF KEY VENDORS
FIGURE 33
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 34
RAPID MICROBIOLOGY TESTING MARKET: BRAND/PRODUCT COMPARISON FOR MALDI-TOF INSTRUMENT
FIGURE 35
BIOMÉRIEUX: COMPANY SNAPSHOT (2025)
FIGURE 36
WATERS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38
ABBOTT LABORATORIES: COMPANY SNAPSHOT (2025)
FIGURE 39
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 40
BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 41
QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42
SARTORIUS AG: COMPANY SNAPSHOT (2025)
FIGURE 43
MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 44
F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2025)
FIGURE 45
CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 46
NEOGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 47
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48
SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 49
RAPID MICRO BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2025)
FIGURE 50
RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 51
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 52
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 53
GLOBAL RAPID MICROBIOLOGY TESTING MARKET: REVENUE SHARE ANALYSIS
FIGURE 54
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 55
TOP-DOWN APPROACH
FIGURE 56
DATA TRIANGULATION METHODOLOGY
Methodology
The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study will examine the competitive landscape of the rapid microbiology testing market by evaluating market participants based on various criteria within the overarching categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
Note: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenue figures were calculated using revenue mapping for major product manufacturers and OEMs active in the global rapid microbiology testing market. All major product manufacturers were identified at the global and/or country-/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global rapid microbiology testing market was split into various segments and subsegments:
- List of major players in the product market by region or country
- Product mapping of various rapid microbiology testing manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from rapid microbiology testing products (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
- Summation of revenue of all companies to arrive at the global rapid microbiology testing market size
Data Triangulation
After determining the overall size of the global rapid microbiology testing market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market-related data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Rapid microbiology testing products are used to rapidly detect, screen, enumerate, and identify microbes and microbial contaminants causing or spreading diseases. These testing procedures include microbial methods that give sensitive and accurate results faster than conventional microbial testing methods.
Key Stakeholders
- Manufacturers and distributors of rapid microbiology tests
- Hospitals & clinics
- Diagnostic centers
- Research & development (R&D) companies
- Clinical research organizations (CROs)
- Research laboratories & academic institutes
- Government associations
- Venture capitalists and investors
Report Objectives
- To define, describe, segment, and forecast the rapid microbiology testing market by product, method, application, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall rapid microbiology testing market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the rapid microbiology testing market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the rapid microbiology testing market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the rapid microbiology testing market
- To benchmark players within the rapid microbiology testing market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
- Further breakdown of the Rest of Europe's rapid microbiology testing market into Russia, Switzerland, Denmark, Austria, and others
- Further breakdown of the Rest of Asia Pacific rapid microbiology testing market into Hong Kong, Taiwan, and others
- Further breakdown of the Rest of Latin American rapid microbiology testing market into Argentina, Colombia, Chile, Ecuador, and others
- Further breakdown of the Southeast Asian rapid microbiology testing market into Malaysia, Singapore, Australia, New Zealand, and others
COMPETITIVE LANDSCAPE ASSESSMENT
- Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the rapid microbiology testing market
- Competitive leadership mapping for established players in the US
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
Fact checked
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Rapid Microbiology Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Rapid Microbiology Testing Market